- Home
- EDSA vs CHNR Comparison
EDSA vs CHNR Comparison
Compare EDSA & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- CHNR
- Stock Information
- Founded
- EDSA 2015
- CHNR N/A
- Country
- EDSA Canada
- CHNR Hong Kong
- Employees
- EDSA N/A
- CHNR N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- EDSA Health Care
- CHNR Basic Materials
- Exchange
- EDSA Nasdaq
- CHNR Nasdaq
- Market Cap
- EDSA 6.2M
- CHNR 5.2M
- IPO Year
- EDSA N/A
- CHNR 1995
- Fundamental
- Price
- EDSA $2.03
- CHNR $0.56
- Analyst Decision
- EDSA Strong Buy
- CHNR
- Analyst Count
- EDSA 1
- CHNR 0
- Target Price
- EDSA $21.00
- CHNR N/A
- AVG Volume (30 Days)
- EDSA 14.5K
- CHNR 50.3K
- Earning Date
- EDSA 05-14-2025
- CHNR 05-15-2025
- Dividend Yield
- EDSA N/A
- CHNR N/A
- EPS Growth
- EDSA N/A
- CHNR N/A
- EPS
- EDSA N/A
- CHNR N/A
- Revenue
- EDSA N/A
- CHNR N/A
- Revenue This Year
- EDSA N/A
- CHNR N/A
- Revenue Next Year
- EDSA N/A
- CHNR N/A
- P/E Ratio
- EDSA N/A
- CHNR N/A
- Revenue Growth
- EDSA N/A
- CHNR N/A
- 52 Week Low
- EDSA $1.55
- CHNR $0.45
- 52 Week High
- EDSA $5.59
- CHNR $1.13
- Technical
- Relative Strength Index (RSI)
- EDSA 36.85
- CHNR 52.58
- Support Level
- EDSA $1.99
- CHNR $0.51
- Resistance Level
- EDSA $2.14
- CHNR $0.66
- Average True Range (ATR)
- EDSA 0.11
- CHNR 0.05
- MACD
- EDSA -0.03
- CHNR 0.00
- Stochastic Oscillator
- EDSA 21.28
- CHNR 35.87
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.